- call +1-201-465-4211
- email sales@mrinsights.biz
Insomnia is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood.
Scope of the Report:
This report studies the Insomnia market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Insomnia market by product type and applications/end industries.
Sleep hygiene and lifestyle changes are typically the first treatment for insomnia. Sleep hygiene includes a consistent bedtime, exposure to sunlight, a quiet and dark room, and regular exercise. Cognitive behavioral therapy may be added to this. While sleeping pills may help, they are associated with injuries, dementia, and addiction.
The global Insomnia market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Insomnia.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Merck
Eisai
Meda Consumer Healthcare
Takeda Pharmaceuticals
Pfizer
Sanofi
Vanda Pharmaceuticals
Pernix Therapeutics
Purdue Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Non-benzodiazepines
Benzodiazepines
Orexin Antagonists
Melatonin Receptor Antagonists
Antihistamines
Melatonin
Valerian Roots
Other Herbal & Dietary Supplements
Market Segment by Applications, can be divided into
Female
Male
Senior Citizens
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Insomnia Market Overview
1.1 Product Overview and Scope of Insomnia
1.2 Classification of Insomnia by Types
1.2.1 Global Insomnia Revenue Comparison by Types (2017-2023)
1.2.2 Global Insomnia Revenue Market Share by Types in 2017
1.2.3 Non-benzodiazepines
1.2.4 Benzodiazepines
1.2.5 Orexin Antagonists
1.2.6 Melatonin Receptor Antagonists
1.2.7 Antihistamines
1.2.8 Melatonin
1.2.9 Valerian Roots
1.2.10 Other Herbal & Dietary Supplements
1.3 Global Insomnia Market by Application
1.3.1 Global Insomnia Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Female
1.3.3 Male
1.3.4 Senior Citizens
1.4 Global Insomnia Market by Regions
1.4.1 Global Insomnia Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Insomnia Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Insomnia Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Insomnia Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Insomnia Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Insomnia Status and Prospect (2013-2023)
1.5 Global Market Size of Insomnia (2013-2023)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Insomnia Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Insomnia Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai
2.2.1 Business Overview
2.2.2 Insomnia Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai Insomnia Revenue, Gross Margin and Market Share (2016-2017)
2.3 Meda Consumer Healthcare
2.3.1 Business Overview
2.3.2 Insomnia Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Meda Consumer Healthcare Insomnia Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda Pharmaceuticals
2.4.1 Business Overview
2.4.2 Insomnia Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Takeda Pharmaceuticals Insomnia Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Insomnia Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Insomnia Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Insomnia Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Insomnia Revenue, Gross Margin and Market Share (2016-2017)
2.7 Vanda Pharmaceuticals
2.7.1 Business Overview
2.7.2 Insomnia Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Vanda Pharmaceuticals Insomnia Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pernix Therapeutics
2.8.1 Business Overview
2.8.2 Insomnia Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pernix Therapeutics Insomnia Revenue, Gross Margin and Market Share (2016-2017)
2.9 Purdue Pharmaceuticals
2.9.1 Business Overview
2.9.2 Insomnia Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Purdue Pharmaceuticals Insomnia Revenue, Gross Margin and Market Share (2016-2017)
3 Global Insomnia Market Competition, by Players
3.1 Global Insomnia Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Insomnia Players Market Share
3.2.2 Top 10 Insomnia Players Market Share
3.3 Market Competition Trend
4 Global Insomnia Market Size by Regions
4.1 Global Insomnia Revenue and Market Share by Regions
4.2 North America Insomnia Revenue and Growth Rate (2013-2018)
4.3 Europe Insomnia Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Insomnia Revenue and Growth Rate (2013-2018)
4.5 South America Insomnia Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Insomnia Revenue and Growth Rate (2013-2018)
5 North America Insomnia Revenue by Countries
5.1 North America Insomnia Revenue by Countries (2013-2018)
5.2 USA Insomnia Revenue and Growth Rate (2013-2018)
5.3 Canada Insomnia Revenue and Growth Rate (2013-2018)
5.4 Mexico Insomnia Revenue and Growth Rate (2013-2018)
6 Europe Insomnia Revenue by Countries
6.1 Europe Insomnia Revenue by Countries (2013-2018)
6.2 Germany Insomnia Revenue and Growth Rate (2013-2018)
6.3 UK Insomnia Revenue and Growth Rate (2013-2018)
6.4 France Insomnia Revenue and Growth Rate (2013-2018)
6.5 Russia Insomnia Revenue and Growth Rate (2013-2018)
6.6 Italy Insomnia Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Insomnia Revenue by Countries
7.1 Asia-Pacific Insomnia Revenue by Countries (2013-2018)
7.2 China Insomnia Revenue and Growth Rate (2013-2018)
7.3 Japan Insomnia Revenue and Growth Rate (2013-2018)
7.4 Korea Insomnia Revenue and Growth Rate (2013-2018)
7.5 India Insomnia Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Insomnia Revenue and Growth Rate (2013-2018)
8 South America Insomnia Revenue by Countries
8.1 South America Insomnia Revenue by Countries (2013-2018)
8.2 Brazil Insomnia Revenue and Growth Rate (2013-2018)
8.3 Argentina Insomnia Revenue and Growth Rate (2013-2018)
8.4 Colombia Insomnia Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Insomnia by Countries
9.1 Middle East and Africa Insomnia Revenue by Countries (2013-2018)
9.2 Saudi Arabia Insomnia Revenue and Growth Rate (2013-2018)
9.3 UAE Insomnia Revenue and Growth Rate (2013-2018)
9.4 Egypt Insomnia Revenue and Growth Rate (2013-2018)
9.5 Nigeria Insomnia Revenue and Growth Rate (2013-2018)
9.6 South Africa Insomnia Revenue and Growth Rate (2013-2018)
10 Global Insomnia Market Segment by Type
10.1 Global Insomnia Revenue and Market Share by Type (2013-2018)
10.2 Global Insomnia Market Forecast by Type (2018-2023)
10.3 Non-benzodiazepines Revenue Growth Rate (2013-2023)
10.4 Benzodiazepines Revenue Growth Rate (2013-2023)
10.5 Orexin Antagonists Revenue Growth Rate (2013-2023)
10.6 Melatonin Receptor Antagonists Revenue Growth Rate (2013-2023)
10.7 Antihistamines Revenue Growth Rate (2013-2023)
10.8 Melatonin Revenue Growth Rate (2013-2023)
10.9 Valerian Roots Revenue Growth Rate (2013-2023)
10.10 Other Herbal & Dietary Supplements Revenue Growth Rate (2013-2023)
11 Global Insomnia Market Segment by Application
11.1 Global Insomnia Revenue Market Share by Application (2013-2018)
11.2 Insomnia Market Forecast by Application (2018-2023)
11.3 Female Revenue Growth (2013-2018)
11.4 Male Revenue Growth (2013-2018)
11.5 Senior Citizens Revenue Growth (2013-2018)
12 Global Insomnia Market Size Forecast (2018-2023)
12.1 Global Insomnia Market Size Forecast (2018-2023)
12.2 Global Insomnia Market Forecast by Regions (2018-2023)
12.3 North America Insomnia Revenue Market Forecast (2018-2023)
12.4 Europe Insomnia Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Insomnia Revenue Market Forecast (2018-2023)
12.6 South America Insomnia Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Insomnia Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Insomnia Picture
Table Product Specifications of Insomnia
Table Global Insomnia and Revenue (Million USD) Market Split by Product Type
Figure Global Ins
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
